Intranasal administration of dolutegravir-loaded nanoemulsion-based in situ gel for enhanced bioavailability and direct brain targeting

HIGHLIGHTS

• who: Anroop B. Nair and colleagues from the Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia have published the article: Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting, in the Journal: Gels 2023, 130 of /2023/
• what: The aim of this study was to develop a nanoemulsion-based in situ gel pArticle size and drug release was carried out using a simplex lattice design. Extensive studies were conducted to explore the feasibility of nanoemulsions in several drug delivery systems . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.